TD Ameritrade Investment Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-177
| Closed | -$8K | – | 594 |
|
|
2022
Q4 | $8K | Sell |
177
-182
| -51% | -$8.23K | ﹤0.01% | 401 |
|
|
2022
Q3 | $14K | Hold |
359
| – | – | ﹤0.01% | 352 |
|
|
2022
Q2 | $13K | Sell |
359
-192
| -35% | -$6.95K | ﹤0.01% | 408 |
|
|
2022
Q1 | $24K | Buy |
551
+192
| +53% | +$8.36K | ﹤0.01% | 404 |
|
|
2021
Q4 | $15K | Sell |
359
-90
| -20% | -$3.76K | ﹤0.01% | 444 |
|
|
2021
Q3 | $17K | Buy |
449
+46
| +11% | +$1.74K | ﹤0.01% | 402 |
|
|
2021
Q2 | $17K | Sell |
403
-23
| -5% | -$970 | ﹤0.01% | 408 |
|
|
2021
Q1 | $15K | Hold |
426
| – | – | ﹤0.01% | 426 |
|
|
2020
Q4 | $15K | Sell |
426
-23
| -5% | -$810 | ﹤0.01% | 426 |
|
|
2020
Q3 | $17K | Buy |
449
+23
| +5% | +$871 | ﹤0.01% | 402 |
|
|
2020
Q2 | $15K | Sell |
426
-3
| -0.7% | -$106 | ﹤0.01% | 394 |
|
|
2020
Q1 | $14K | Sell |
429
-74
| -15% | -$2.42K | ﹤0.01% | 382 |
|
|
2019
Q4 | $23K | Buy |
503
+342
| +212% | +$15.6K | ﹤0.01% | 378 |
|
|
2019
Q3 | $7K | Sell |
161
-29
| -15% | -$1.26K | ﹤0.01% | 473 |
|
|
2019
Q2 | $8K | Buy |
190
+24
| +14% | +$1.01K | ﹤0.01% | 426 |
|
|
2019
Q1 | $6K | Sell |
166
-267
| -62% | -$9.65K | ﹤0.01% | 418 |
|
|
2018
Q4 | $15K | Buy |
433
+334
| +337% | +$11.6K | ﹤0.01% | 313 |
|
|
2018
Q3 | $4K | Buy |
99
+38
| +62% | +$1.54K | ﹤0.01% | 413 |
|
|
2018
Q2 | $2K | Buy |
+61
| New | +$2K | ﹤0.01% | 335 |
|